Type II Endometrial Cancer Overexpresses NILCO: A Preliminary Evaluation

Figure 2

HSCORE values from lean and obese African-American women. (a) HSCORE of lean type I (; 42%) versus lean type II (; 58%). (b) HSCORE of lean type I (; 42%) versus obese type I (; 41%). (c) HSCORE of lean type II (; 58%) versus obese type II (; 59%). The expression levels of NILCO components and targets were analyzed in EmCa from lean () versus obese () women. .

(a)

(b)

(c)